Effect of magnesium chloride on electrical stability of the heart - PubMed (original) (raw)
Comparative Study
Effect of magnesium chloride on electrical stability of the heart
M F Ghani et al. Am Heart J. 1977 Nov.
Abstract
The effect of magnesium chloride on the ventricular fibrillation threshold (VFT) and the threshold for the ventricular premature contraction (VPCT) was studied in 20 dogs. Seven of the dogs were pre-treated with digitalis and four were in the form of heart-lung preparations. In the anesthetized, intact dogs, the VPCT was 0.19 +/- 0.01 mV. After treatment with magnesium chloride (100 mg. per kilogram intravenously), the VPCT increased by 53% (P less than 0.01). In the same group of animals, the VFT averaged 0.50 +/- 0.06 mV., which more than doubled after administration of magnesium. The threshold of VPC in the digitalis-treated dogs measured 0.18 +/- 0.01 mV; this value doubled after magnesium. The VFT in the digitalized dogs also increased after magnesium; however, resistance to electrical defibrillation was encountered in this group. In the heart-lung preparations, VPCT improved by 72% and a gain of 131% in the VFT followed magnesium administration. The results suggest that magnesium increases the ventricular threshold of arrhythmias in normal, denervated (heart-lung preparations) and also digitalis-treated hearts and, thus, indicate its usefulness in the treatment of ventricular arrhythmias.
Similar articles
- Dependence of defibrillation threshold upon extracellular/intracellular K+ concentrations.
Babbs CF, Whistler SJ, Yim GK, Tacker WA, Geddes LA. Babbs CF, et al. J Electrocardiol. 1980;13(1):73-8. doi: 10.1016/s0022-0736(80)80013-6. J Electrocardiol. 1980. PMID: 7359067 - Effects of ganglionated plexi ablation on ventricular electrophysiological properties in normal hearts and after acute myocardial ischemia.
He B, Lu Z, He W, Wu L, Cui B, Hu X, Yu L, Huang C, Jiang H. He B, et al. Int J Cardiol. 2013 Sep 20;168(1):86-93. doi: 10.1016/j.ijcard.2012.09.067. Epub 2012 Oct 2. Int J Cardiol. 2013. PMID: 23041007 - [Mechanisms involved in the antiarrhythmic and proarrhythmic effects of magnesium].
Grin J, Pellizzón OA, Raynald A. Grin J, et al. Medicina (B Aires). 1996;56(3):231-40. Medicina (B Aires). 1996. PMID: 9035478 Spanish. - Effects of magnesium sulfate on electrical ventricular defibrillation of dogs.
McDaniel WC, Curtis JJ, Walls JT, Madsen RW. McDaniel WC, et al. J Electrocardiol. 1998 Apr;31(2):137-43. doi: 10.1016/s0022-0736(98)90045-0. J Electrocardiol. 1998. PMID: 9588660 - Antifibrillatory action of the narcotic agonist fentanyl.
Saini V, Carr DB, Hagestad EL, Lown B, Verrier RL. Saini V, et al. Am Heart J. 1988 Mar;115(3):598-605. doi: 10.1016/0002-8703(88)90810-1. Am Heart J. 1988. PMID: 3278576 Review.
Cited by
- Magnesium, myocardial ischaemia and arrhythmias. The role of magnesium in myocardial infarction.
Dubey A, Solomon R. Dubey A, et al. Drugs. 1989 Jan;37(1):1-7. doi: 10.2165/00003495-198937010-00001. Drugs. 1989. PMID: 2651085 Review. No abstract available. - The influence of elevated Mg2+ concentrations on cardiac electrophysiologic parameters.
Stark G, Stark U, Pilger E, Hönigl K, Bertuch H, Tritthart HA. Stark G, et al. Cardiovasc Drugs Ther. 1989 Apr;3(2):183-9. doi: 10.1007/BF01883863. Cardiovasc Drugs Ther. 1989. PMID: 2484855 - Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials.
Teo KK, Yusuf S, Collins R, Held PH, Peto R. Teo KK, et al. BMJ. 1991 Dec 14;303(6816):1499-503. doi: 10.1136/bmj.303.6816.1499. BMJ. 1991. PMID: 1838289 Free PMC article. Clinical Trial. - Ventricular arrhythmias in patients with myocardial infarction and ischaemia. Relationship to serum potassium and magnesium.
Solomon RJ. Solomon RJ. Drugs. 1984 Oct;28 Suppl 1:66-76. doi: 10.2165/00003495-198400281-00007. Drugs. 1984. PMID: 6499704 - Increase in magnesium plasma level after orally administered trimagnesium dicitrate.
Wilimzig C, Latz R, Vierling W, Mutschler E, Trnovec T, Nyulassy S. Wilimzig C, et al. Eur J Clin Pharmacol. 1996;49(4):317-23. doi: 10.1007/BF00226334. Eur J Clin Pharmacol. 1996. PMID: 8857079 Clinical Trial.